1
|
Gul A, Ahmad M, Ullah R, Ullah R, Kang Y, Liao W. Systematic review on antibacterial photodynamic therapeutic effects of transition metals ruthenium and iridium complexes. J Inorg Biochem 2024; 255:112523. [PMID: 38489864 DOI: 10.1016/j.jinorgbio.2024.112523] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2023] [Revised: 02/29/2024] [Accepted: 03/10/2024] [Indexed: 03/17/2024]
Abstract
The prevalence of antibiotic-resistant pathogenic bacteria poses a significant threat to public health and ranks among the principal causes of morbidity and mortality worldwide. Antimicrobial photodynamic therapy is an emerging therapeutic technique that has excellent potential to embark upon antibiotic resistance problems. The efficacy of this therapy hinges on the careful selection of suitable photosensitizers (PSs). Transition metal complexes, such as Ruthenium (Ru) and Iridium (Ir), are highly suitable for use as PSs because of their surface plasmonic resonance, crystal structure, optical characteristics, and photonics. These metals belong to the platinum family and exhibit similar chemical behavior due to their partially filled d-shells. Ruthenium and Iridium-based complexes generate reactive oxygen species (ROS), which interact with proteins and DNA to induce cell death. As photodynamic therapeutic agents, these complexes have been widely studied for their efficacy against cancer cells, but their potential for antibacterial activity remains largely unexplored. Our study focuses on exploring the antibacterial photodynamic effect of Ruthenium and Iridium-based complexes against both Gram-positive and Gram-negative bacteria. We aim to provide a comprehensive overview of various types of research in this area, including the structures, synthesis methods, and antibacterial photodynamic applications of these complexes. Our findings will provide valuable insights into the design, development, and modification of PSs to enhance their photodynamic therapeutic effect on bacteria, along with a clear understanding of their mechanism of action.
Collapse
Affiliation(s)
- Anadil Gul
- College of Applied Sciences, Shenzhen University, Shenzhen 518060, China; Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen 518060, China; College of Health Science and Environmental Engineering, Shenzhen Technology University, Pingshan District, Shenzhen 518118, China
| | - Munir Ahmad
- Shenzhen Key Laboratory of Advanced Thin Films and Applications, Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, Guangdong, China
| | - Raza Ullah
- College of Materials Science and Engineering, Institute of Biomedical Materials and Engineering, Qingdao University, Qingdao 266071, China
| | - Rizwan Ullah
- School of Physics, University of Electronic Science and Technology of China, Chengdu 610054, China
| | - Yan Kang
- College of Applied Sciences, Shenzhen University, Shenzhen 518060, China; Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen 518060, China; College of Health Science and Environmental Engineering, Shenzhen Technology University, Pingshan District, Shenzhen 518118, China.
| | - Wenchao Liao
- College of Health Science and Environmental Engineering, Shenzhen Technology University, Pingshan District, Shenzhen 518118, China.
| |
Collapse
|
2
|
Bugnon Q, Melendez C, Desiatkina O, Fayolles de Chaptes L, Holzer I, Păunescu E, Hilty M, Furrer J. In vitro antibacterial activity of dinuclear thiolato-bridged ruthenium(II)-arene compounds. Microbiol Spectr 2023; 11:e0095423. [PMID: 37815336 PMCID: PMC10714934 DOI: 10.1128/spectrum.00954-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2023] [Accepted: 08/28/2023] [Indexed: 10/11/2023] Open
Abstract
IMPORTANCE The in vitro assessment of diruthenium(II)-arene compounds against Escherichia coli, Streptococcus pneumoniae, and Staphylococcus aureus showed a significant antibacterial activity of some compounds against S. pneumoniae, with minimum inhibitory concentration (MIC) values ranging from 1.3 to 2.6 µM, and a medium activity against E. coli, with MIC of 25 µM. The nature of the substituents anchored on the bridging thiols and the compounds molecular weight appear to significantly influence the antibacterial activity. Fluorescence microscopy showed that these ruthenium compounds enter the bacteria and do not accumulate in the cell wall of gram-positive bacteria. These diruthenium(II)-arene compounds exhibit promising activity against S. aureus and S. pneumoniae and deserve to be considered for further studies, especially the compounds bearing larger benzo-fused lactam substituents.
Collapse
Affiliation(s)
- Quentin Bugnon
- Department of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland
- Department of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern, Bern, Switzerland
| | - Camilo Melendez
- Department of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern, Bern, Switzerland
| | - Oksana Desiatkina
- Department of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern, Bern, Switzerland
| | - Louis Fayolles de Chaptes
- Department of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern, Bern, Switzerland
| | - Isabelle Holzer
- Department of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern, Bern, Switzerland
| | - Emilia Păunescu
- Department of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern, Bern, Switzerland
| | - Markus Hilty
- Department of Medicine, Institute for Infectious Diseases, University of Bern, Bern, Switzerland
| | - Julien Furrer
- Department of Chemistry, Biochemistry and Pharmaceuticals Sciences, University of Bern, Bern, Switzerland
| |
Collapse
|
3
|
Zhang Y, Doan BT, Gasser G. Metal-Based Photosensitizers as Inducers of Regulated Cell Death Mechanisms. Chem Rev 2023; 123:10135-10155. [PMID: 37534710 DOI: 10.1021/acs.chemrev.3c00161] [Citation(s) in RCA: 22] [Impact Index Per Article: 22.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/04/2023]
Abstract
Over the last few decades, various forms of regulated cell death (RCD) have been discovered and were found to improve cancer treatment. Although there are several reviews on RCD induced by photodynamic therapy (PDT), a comprehensive summary covering metal-based photosensitizers (PSs) as RCD inducers has not yet been presented. In this review, we systematically summarize the works on metal-based PSs that induce different types of RCD, including ferroptosis, immunogenic cell death (ICD), and pyroptosis. The characteristics and mechanisms of each RCD are explained. At the end of each section, a summary of the reported commonalities between different metal-based PSs inducing the same RCD is emphasized, and future perspectives on metal-based PSs inducing novel forms of RCD are discussed at the end of the review. Considering the essential roles of metal-based PSs and RCD in cancer therapy, we hope that this review will provide the stage for future advances in metal-based PSs as RCD inducers.
Collapse
Affiliation(s)
- Yiyi Zhang
- Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemistry, 75005 Paris, France
| | - Bich-Thuy Doan
- Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory of Synthesis, Electrochemistry, Imaging and Analytical Systems for Diagnosis, 75005 Paris, France
| | - Gilles Gasser
- Chimie ParisTech, PSL University, CNRS, Institute of Chemistry for Life and Health Sciences, Laboratory for Inorganic Chemistry, 75005 Paris, France
| |
Collapse
|
4
|
Frei A, Verderosa AD, Elliott AG, Zuegg J, Blaskovich MAT. Metals to combat antimicrobial resistance. Nat Rev Chem 2023; 7:202-224. [PMID: 37117903 PMCID: PMC9907218 DOI: 10.1038/s41570-023-00463-4] [Citation(s) in RCA: 100] [Impact Index Per Article: 100.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/06/2023] [Indexed: 02/10/2023]
Abstract
Bacteria, similar to most organisms, have a love-hate relationship with metals: a specific metal may be essential for survival yet toxic in certain forms and concentrations. Metal ions have a long history of antimicrobial activity and have received increasing attention in recent years owing to the rise of antimicrobial resistance. The search for antibacterial agents now encompasses metal ions, nanoparticles and metal complexes with antimicrobial activity ('metalloantibiotics'). Although yet to be advanced to the clinic, metalloantibiotics are a vast and underexplored group of compounds that could lead to a much-needed new class of antibiotics. This Review summarizes recent developments in this growing field, focusing on advances in the development of metalloantibiotics, in particular, those for which the mechanism of action has been investigated. We also provide an overview of alternative uses of metal complexes to combat bacterial infections, including antimicrobial photodynamic therapy and radionuclide diagnosis of bacterial infections.
Collapse
Affiliation(s)
- Angelo Frei
- Community for Open Antimicrobial Drug Discovery, Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia.
- Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Bern, Switzerland.
| | - Anthony D Verderosa
- Community for Open Antimicrobial Drug Discovery, Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia
| | - Alysha G Elliott
- Community for Open Antimicrobial Drug Discovery, Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia
| | - Johannes Zuegg
- Community for Open Antimicrobial Drug Discovery, Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia
| | - Mark A T Blaskovich
- Community for Open Antimicrobial Drug Discovery, Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia.
| |
Collapse
|
5
|
Busto N, Vigueras G, Cutillas N, García B, Ruiz J. Inert cationic iridium(III) complexes with phenanthroline-based ligands: application in antimicrobial inactivation of multidrug-resistant bacterial strains. Dalton Trans 2022; 51:9653-9663. [PMID: 35713595 DOI: 10.1039/d2dt00752e] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
The antimicrobial activity of a new series of heteroleptic iridium(III) complexes of the type [Ir(C^N)2(N^N)][PF6] (C^N = deprotonated 2-phenylbenzimidazole-κN, κC; N^N = phen (Ir1), dpq (Ir2), dppz (Ir3), dppn (Ir4), and dppz-idzo (Ir5)) was studied towards two Gram positive (vancomycin-resistant Enterococcus faecium and a methicillin-resistant Staphylococcus aureus) and two Gram negative (Acinetobacter baumanii and Pseudomonas aeruginosa) multidrug-resistant bacterial strains of clinical interest. Although the complexes were inactive towards Gram negative bacteria, their effectiveness against Gram positive strains was remarkable, especially for Ir1 and Ir2, the most bactericidal complexes that were even more active (10 times) than the fluoroquinolone antibiotic norfloxacin and displayed no toxicity in human kidney cells (HEK293). Mechanistic studies revealed that the cell wall and membrane of MRSA S. aureus remained intact on treatment with these compounds and that DNA was not their main target. It is important to note that the complexes were able to induce ROS generation, this being the feature key to their antimicrobial activity.
Collapse
Affiliation(s)
- Natalia Busto
- Departamento de Química, Facultad de Ciencias, Universidad de Burgos, Plaza Misael Bañuelos s/n, E-09001, Burgos, Spain. .,Departamento de Ciencias de la Salud. Facultad de Ciencias de la Salud. Universidad de Burgos, Hospital Militar, Paseo de los Comendadores, s/n, 09001 Burgos, Spain.
| | - Gloria Vigueras
- Departamento de Química Inorgánica, Universidad de Murcia, and Biomedical Research Institute of Murcia (IMIB-Arrixaca), E-30071 Murcia, Spain.
| | - Natalia Cutillas
- Departamento de Química Inorgánica, Universidad de Murcia, and Biomedical Research Institute of Murcia (IMIB-Arrixaca), E-30071 Murcia, Spain.
| | - Begoña García
- Departamento de Química, Facultad de Ciencias, Universidad de Burgos, Plaza Misael Bañuelos s/n, E-09001, Burgos, Spain.
| | - José Ruiz
- Departamento de Química Inorgánica, Universidad de Murcia, and Biomedical Research Institute of Murcia (IMIB-Arrixaca), E-30071 Murcia, Spain.
| |
Collapse
|
6
|
Wang L, Huang B, Duan X, Jiang G, Xiong Y, Zhong S, Wang J, Liao X. The development of three ruthenium-based antimicrobial metallodrugs: Design, synthesis, and activity evaluation against Staphylococcus aureus. JOURNAL OF CHEMICAL RESEARCH 2021. [DOI: 10.1177/17475198211055098] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
The development of new classes of antimicrobial is urgently needed due to the widespread occurrence of multi-resistant pathogens. In this study, three novel ruthenium complexes: [Ru(dmob)2(BTPIP)](PF6)2 (Ru(II)-1), [Ru(dbp)2(BTPIP)](PF6)2 (Ru(II)-2), and [Ru(dpa)2(BTPIP)](PF6)2 (Ru(II)-3) (dpa = 2,2’-dipyridylamine, dmob = 4,4’-dimethoxy-2,2’-bipyridyl, dbp = 4,4’-di- tert-butyl-2,2’-dipyridyl, BTPIP = 4-(benzo[ b]thiophen-2-yl)phenyl-1 H-imidazo[4,5- f][1,10]phenanthroline) are synthesized and investigated as antimicrobial metallodrugs. We demonstrate that all three complexes have significant antimicrobial activity against Staphylococcus aureus by testing their minimal inhibitory concentrations = 0.0015–0.0125 mg/mL. The antibacterial activity of the best active complex Ru(II)-3 is 13 times that of ofloxacin (minimal inhibitory concentration = 19.5 μg/mL). Importantly, Ru(II)-3 not only increases the susceptibility of Staphylococcus aureus to existing common antibiotics but also shows noticeably delayed and decreased resistance in Staphylococcus aureus since the minimal inhibitory concentration values of Ru(II)-3 only increased eightfold times after 20 passages. Furthermore, the biofilms formation and rabbit erythrocyte hemolysis assays verified that Ru(II)-3 also efficiently inhibit the biofilm formation and toxin secretion of Staphylococcus aureus.
Collapse
Affiliation(s)
- Liqiang Wang
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, P.R. China
| | - Bin Huang
- School of Pharmaceutical Sciences, Hunan University of Medicine, Huaihua, P.R. China
| | - Xuemin Duan
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, P.R. China
| | - Guijuan Jiang
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, P.R. China
| | - Yanshi Xiong
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, P.R. China
| | - Shengfei Zhong
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, P.R. China
| | - Jintao Wang
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, P.R. China
| | - Xiangwen Liao
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, P.R. China
| |
Collapse
|
7
|
Liao X, Wang J, Jiang G, Lingyu M, Jiang G, Wang J, Huang B. Identification of ruthenium (II) complexes with furan-substituted ligands as possible antibacterial agents against Staphylococcus aureus. Chem Biol Drug Des 2021; 98:885-893. [PMID: 34453495 DOI: 10.1111/cbdd.13943] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2021] [Revised: 07/23/2021] [Accepted: 08/01/2021] [Indexed: 11/28/2022]
Abstract
The growing burden of antibiotic resistance worldwide calls for developing new classes of antimicrobial strategy. Recently years, the use of adjuvants that rescue antibiotics identified as a promising strategy for overcoming bacterial resistance. In this study, three ruthenium complexes functionalized with furan-substituted ligands([Ru(phen)2 (CAPIP)](ClO4 )2 (Ru(Ⅱ)-1), [Ru(dmp)2 (CAPIP)](ClO4 )2 (Ru(Ⅱ)-2) and [Ru(dmb)2 (CAPIP)](ClO4 )2 (Ru(Ⅱ)-3) (dmb=4,4'-dimethyl-2,2'-bipyridine, phen=1,10-phenanthroline, dmp=2,9-dimethyl-1,10-phenanthroline, CAPIP=(E)-2- (2-(furan-2-yl)vinyl)-1H-imidazo[4,5-f][1,10]phenanthroline)) were designed and synthesized. The antimicrobial activities of all compounds against S. aureus were assessed by growth inhibition assays. The MIC values of three complexes range from 0.015 to 0.050 mg/ml. Subsequently, the Ru(II)-2 complexes which exhibited strongest antibacterial activity were further tested against bacteria biofilms formation and toxin secretion. In addition, aimed to test whether ruthenium complexes have potential value as antimicrobial adjuvants, the synergism between Ru(Ⅱ)-2 and some antibiotics against S. aureus were examined through checkerboard method. Interestingly, Ru(Ⅱ)-2 could not only effectively inhibit biofilms formation of S. aureus and inhibit the hemolysin toxin secretion, but also selectivity show synergism with two common antibiotics. More importantly, mouse infection study also verified Ru(Ⅱ)-2 were highly effective against S. aureus in vivo.
Collapse
Affiliation(s)
- Xiangwen Liao
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China
| | - Jing Wang
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China
| | - Guijuan Jiang
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China
| | - Mao Lingyu
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China
| | - Guangbin Jiang
- Guangxi Key Laboratory of Electrochemical and Magneto-chemical Function Materials, College of Chemistry and Bioengineering, Guilin University of Technology, Guilin, China
| | - Jintao Wang
- Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, China
| | - Bin Huang
- School of Pharmaceutical Sciences, Hunan University of Medicine, Huaihua, China
| |
Collapse
|
8
|
Munteanu AC, Uivarosi V. Ruthenium Complexes in the Fight against Pathogenic Microorganisms. An Extensive Review. Pharmaceutics 2021; 13:874. [PMID: 34199283 PMCID: PMC8232020 DOI: 10.3390/pharmaceutics13060874] [Citation(s) in RCA: 36] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2021] [Revised: 06/07/2021] [Accepted: 06/09/2021] [Indexed: 12/13/2022] Open
Abstract
The widespread use of antibiotics has resulted in the emergence of drug-resistant populations of microorganisms. Clearly, one can see the need to develop new, more effective, antimicrobial agents that go beyond the explored 'chemical space'. In this regard, their unique modes of action (e.g., reactive oxygen species (ROS) generation, redox activation, ligand exchange, depletion of substrates involved in vital cellular processes) render metal complexes as promising drug candidates. Several Ru (II/III) complexes have been included in, or are currently undergoing, clinical trials as anticancer agents. Based on the in-depth knowledge of their chemical properties and biological behavior, the interest in developing new ruthenium compounds as antibiotic, antifungal, antiparasitic, or antiviral drugs has risen. This review will discuss the advantages and disadvantages of Ru (II/III) frameworks as antimicrobial agents. Some aspects regarding the relationship between their chemical structure and mechanism of action, cellular localization, and/or metabolism of the ruthenium complexes in bacterial and eukaryotic cells are discussed as well. Regarding the antiviral activity, in light of current events related to the Covid-19 pandemic, the Ru (II/III) compounds used against SARS-CoV-2 (e.g., BOLD-100) are also reviewed herein.
Collapse
Affiliation(s)
- Alexandra-Cristina Munteanu
- Department of General and Inorganic Chemistry, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, Romania
| | - Valentina Uivarosi
- Department of General and Inorganic Chemistry, Faculty of Pharmacy, “Carol Davila” University of Medicine and Pharmacy, 020956 Bucharest, Romania
| |
Collapse
|
9
|
Hohlfeld BF, Gitter B, Kingsbury CJ, Flanagan KJ, Steen D, Wieland GD, Kulak N, Senge MO, Wiehe A. Dipyrrinato-Iridium(III) Complexes for Application in Photodynamic Therapy and Antimicrobial Photodynamic Inactivation. Chemistry 2021; 27:6440-6459. [PMID: 33236800 PMCID: PMC8248005 DOI: 10.1002/chem.202004776] [Citation(s) in RCA: 31] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Revised: 11/24/2020] [Indexed: 12/24/2022]
Abstract
The generation of bio-targetable photosensitizers is of utmost importance to the emerging field of photodynamic therapy and antimicrobial (photo-)therapy. A synthetic strategy is presented in which chelating dipyrrin moieties are used to enhance the known photoactivity of iridium(III) metal complexes. Formed complexes can thus be functionalized in a facile manner with a range of targeting groups at their chemically active reaction sites. Dipyrrins with N- and O-substituents afforded (dipy)iridium(III) complexes via complexation with the respective Cp*-iridium(III) and ppy-iridium(III) precursors (dipy=dipyrrinato, Cp*=pentamethyl-η5 -cyclopentadienyl, ppy=2-phenylpyridyl). Similarly, electron-deficient [IrIII (dipy)(ppy)2 ] complexes could be used for post-functionalization, forming alkenyl, alkynyl and glyco-appended iridium(III) complexes. The phototoxic activity of these complexes has been assessed in cellular and bacterial assays with and without light; the [IrIII (Cl)(Cp*)(dipy)] complexes and the glyco-substituted iridium(III) complexes showing particular promise as photomedicine candidates. Representative crystal structures of the complexes are also presented.
Collapse
Affiliation(s)
- Benjamin F. Hohlfeld
- Institut für Chemie u. BiochemieFreie Universität BerlinTakustr. 314195BerlinGermany
- biolitec research GmbHOtto-Schott-Str. 1507745JenaGermany
| | | | - Christopher J. Kingsbury
- Medicinal Chemistry, Trinity Translational Medicine InstituteTrinity Centre for Health SciencesTrinity College Dublin, The University of DublinSt James's HospitalDublin8Ireland
| | - Keith J. Flanagan
- Medicinal Chemistry, Trinity Translational Medicine InstituteTrinity Centre for Health SciencesTrinity College Dublin, The University of DublinSt James's HospitalDublin8Ireland
| | - Dorika Steen
- biolitec research GmbHOtto-Schott-Str. 1507745JenaGermany
| | | | - Nora Kulak
- Institut für Chemie u. BiochemieFreie Universität BerlinTakustr. 314195BerlinGermany
- Institut für ChemieOtto-von-Guericke-Universität MagdeburgUniversitätsplatz 239106MagdeburgGermany
| | - Mathias O. Senge
- Medicinal Chemistry, Trinity Translational Medicine InstituteTrinity Centre for Health SciencesTrinity College Dublin, The University of DublinSt James's HospitalDublin8Ireland
- Institute for Advanced Study (TUM-IAS)Technical University of MunichLichtenbergstrasse 2a85748GarchingGermany
| | - Arno Wiehe
- Institut für Chemie u. BiochemieFreie Universität BerlinTakustr. 314195BerlinGermany
- biolitec research GmbHOtto-Schott-Str. 1507745JenaGermany
| |
Collapse
|
10
|
Ghosh S, Amariei G, Mosquera MEG, Rosal R. Polymeric ruthenium precursor as a photoactivated antimicrobial agent. JOURNAL OF HAZARDOUS MATERIALS 2021; 402:123788. [PMID: 33254797 DOI: 10.1016/j.jhazmat.2020.123788] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/18/2020] [Revised: 07/29/2020] [Accepted: 08/19/2020] [Indexed: 06/12/2023]
Abstract
Ruthenium coordination compounds have demonstrated a promising anticancer and antibacterial activity, but their poor water solubility and low stability under physiological conditions may limit their therapeutic applications. Physical encapsulation or covalent conjugation with polymers may overcome these drawbacks, but generally involve multistep reactions and purification processes. In this work, the antibacterial activity of the polymeric precursor dicarbonyldichlororuthenium (II) [Ru(CO)2Cl2]n has been studied against Escherichia coli and Staphylococcus aureus. This Ru-carbonyl precursor shows minimum inhibitory concentration at nanogram per millilitre, which renders it a novel antimicrobial polymer without any organic ligands. Besides, [Ru(CO)2Cl2]n antimicrobial activity is markedly boosted under photoirradiation, which can be ascribed to the enhanced generation of reactive oxygen species under UV irradiation. [Ru(CO)2Cl2]n has been able to inhibit bacterial growth via the disruption of bacterial membranes and triggering upregulation of stress responses as shown in microscopic measurements. The activity of polymeric ruthenium as an antibacterial material is significant even at 6.6 ng/mL while remaining biocompatible to the mammalian cells at much higher concentrations. This study proves that this simple precursor, [Ru(CO)2Cl2]n, can be used as an antimicrobial compound with high activity and a low toxicity profile in the context of need for new antimicrobial agents to fight bacterial infections.
Collapse
Affiliation(s)
- Srabanti Ghosh
- Department of Organic and Inorganic Chemistry, Instituto de Investigación en Química "Andrés M. del Río" (IQAR), Universidad de Alcalá, Campus Universitario, 28805, Alcalá de Henares, Madrid, Spain.
| | - Georgiana Amariei
- Department of Chemical Engineering, Universidad de Alcalá, Campus Universitario, 28805, Alcalá de Henares, Madrid, Spain
| | - Marta E G Mosquera
- Department of Organic and Inorganic Chemistry, Instituto de Investigación en Química "Andrés M. del Río" (IQAR), Universidad de Alcalá, Campus Universitario, 28805, Alcalá de Henares, Madrid, Spain.
| | - Roberto Rosal
- Department of Chemical Engineering, Universidad de Alcalá, Campus Universitario, 28805, Alcalá de Henares, Madrid, Spain
| |
Collapse
|
11
|
Zeng H, Stewart-Yates L, Casey LM, Bampos N, Roberts DA. Covalent Post-Assembly Modification: A Synthetic Multipurpose Tool in Supramolecular Chemistry. Chempluschem 2020; 85:1249-1269. [PMID: 32529789 DOI: 10.1002/cplu.202000279] [Citation(s) in RCA: 19] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2020] [Revised: 05/25/2020] [Indexed: 11/10/2022]
Abstract
The use of covalent post-assembly modification (PAM) in supramolecular chemistry has grown significantly in recent years, to the point where PAM is now a versatile synthesis tool for tuning, modulating, and expanding the functionality of self-assembled complexes and materials. PAM underpins supramolecular template-synthesis strategies, enables modular derivatization of supramolecular assemblies, permits the covalent 'locking' of unstable structures, and can trigger controlled structural transformations between different assembled morphologies. This Review discusses key examples of PAM spanning a range of material classes, including discrete supramolecular complexes, self-assembled soft nanostructures and hierarchically ordered polymeric and framework materials. As such, we hope to highlight how PAM has continued to evolve as a creative and functional addition to the synthetic chemist's toolbox for constructing bespoke self-assembled complexes and materials.
Collapse
Affiliation(s)
- Haoxiang Zeng
- School of Chemistry and Key Center for Polymers and Colloids, The University of Sydney, Sydney, NSW 2006, Australia
| | - Luke Stewart-Yates
- School of Chemistry and Key Center for Polymers and Colloids, The University of Sydney, Sydney, NSW 2006, Australia
| | - Louis M Casey
- School of Chemistry and Key Center for Polymers and Colloids, The University of Sydney, Sydney, NSW 2006, Australia
| | - Nick Bampos
- Department of Chemistry, The University of Cambridge, Cambridge, CB2 1EW, United Kingdom
| | - Derrick A Roberts
- School of Chemistry and Key Center for Polymers and Colloids, The University of Sydney, Sydney, NSW 2006, Australia
| |
Collapse
|
12
|
Abstract
Traditional organic antimicrobials mainly act on specific biochemical processes such as replication, transcription and translation. However, the emergence and wide spread of microbial resistance is a growing threat for human beings. Therefore, it is highly necessary to design strategies for the development of new drugs in order to target multiple cellular processes that should improve their efficiency against several microorganisms, including bacteria, viruses or fungi. The present review is focused on recent advances and findings of new antimicrobial strategies based on metal complexes. Recent studies indicate that some metal ions cause different types of damages to microbial cells as a result of membrane degradation, protein dysfunction and oxidative stress. These unique modes of action, combined with the wide range of three-dimensional geometries that metal complexes can adopt, make them suitable for the development of new antimicrobial drugs.
Collapse
|
13
|
Frei A, Zuegg J, Elliott AG, Baker M, Braese S, Brown C, Chen F, G Dowson C, Dujardin G, Jung N, King AP, Mansour AM, Massi M, Moat J, Mohamed HA, Renfrew AK, Rutledge PJ, Sadler PJ, Todd MH, Willans CE, Wilson JJ, Cooper MA, Blaskovich MAT. Metal complexes as a promising source for new antibiotics. Chem Sci 2020; 11:2627-2639. [PMID: 32206266 PMCID: PMC7069370 DOI: 10.1039/c9sc06460e] [Citation(s) in RCA: 228] [Impact Index Per Article: 57.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2019] [Accepted: 02/10/2020] [Indexed: 12/16/2022] Open
Abstract
There is a dire need for new antimicrobial compounds to combat the growing threat of widespread antibiotic resistance. With a currently very scarce drug pipeline, consisting mostly of derivatives of known antibiotics, new classes of antibiotics are urgently required. Metal complexes are currently in clinical development for the treatment of cancer, malaria and neurodegenerative diseases. However, only little attention has been paid to their application as potential antimicrobial compounds. We report the evaluation of 906 metal-containing compounds that have been screened by the Community for Open Antimicrobial Drug Discovery (CO-ADD) for antimicrobial activity. Metal-bearing compounds display a significantly higher hit-rate (9.9%) when compared to the purely organic molecules (0.87%) in the CO-ADD database. Out of 906 compounds, 88 show activity against at least one of the tested strains, including fungi, while not displaying any cytotoxicity against mammalian cell lines or haemolytic properties. Herein, we highlight the structures of the 30 compounds with activity against Gram-positive and/or Gram-negative bacteria containing Mn, Co, Zn, Ru, Ag, Eu, Ir and Pt, with activities down to the nanomolar range against methicillin resistant S. aureus (MRSA). 23 of these complexes have not been reported for their antimicrobial properties before. This work reveals the vast diversity that metal-containing compounds can bring to antimicrobial research. It is important to raise awareness of these types of compounds for the design of truly novel antibiotics with potential for combatting antimicrobial resistance.
Collapse
Affiliation(s)
- Angelo Frei
- Centre for Superbug Solutions , Institute for Molecular Bioscience , The University of Queensland , St. Lucia , Queensland 4072 , Australia . ;
| | - Johannes Zuegg
- Centre for Superbug Solutions , Institute for Molecular Bioscience , The University of Queensland , St. Lucia , Queensland 4072 , Australia . ;
| | - Alysha G Elliott
- Centre for Superbug Solutions , Institute for Molecular Bioscience , The University of Queensland , St. Lucia , Queensland 4072 , Australia . ;
| | - Murray Baker
- School of Molecular Sciences , The University of Western Australia , Stirling Highway , 6009 Perth , Australia
| | - Stefan Braese
- Institute of Organic Chemistry , Karlsruhe Institute of Technology (KIT) , Fritz-Haber-Weg 6 , 76131 Karlsruhe , Germany
- Institute of Biological and Chemical Systems - Functional Molecular Systems (IBCS-FMS) , Karlsruhe Institute of Technology (KIT) , Hermann-von-Helmholtz-Platz 1 , D-76344 Eggenstein-Leopoldshafen , Germany
| | - Christopher Brown
- School of Medical Sciences (Discipline of Pharmacology) , University of Sydney , Australia
| | - Feng Chen
- Department of Chemistry , University of Warwick , Gibbet Hill Road , Coventry CV4 7AL , UK
| | - Christopher G Dowson
- Antimicrobial Screening Facility , School of Life Sciences , University of Warwick , Gibbet Hill Road , Coventry CV4 7AL , UK
| | - Gilles Dujardin
- Institute of Molecules and Matter of Le Mans (IMMM) , UMR 6283 CNRS , Le Mans Université , France
| | - Nicole Jung
- Institute of Organic Chemistry , Karlsruhe Institute of Technology (KIT) , Fritz-Haber-Weg 6 , 76131 Karlsruhe , Germany
- Institute of Biological and Chemical Systems - Functional Molecular Systems (IBCS-FMS) , Karlsruhe Institute of Technology (KIT) , Hermann-von-Helmholtz-Platz 1 , D-76344 Eggenstein-Leopoldshafen , Germany
| | - A Paden King
- Department of Chemistry and Chemical Biology , Cornell University , Ithaca , NY 14853 , USA
| | - Ahmed M Mansour
- Chemistry Department , Faculty of Science , Cairo University , Egypt
| | - Massimiliano Massi
- School of Molecular and Life Sciences - Curtin Institute for Functional Materials and Interfaces , Curtin University , Kent Street , 6102 Bentley WA , Australia
| | - John Moat
- Antimicrobial Screening Facility , School of Life Sciences , University of Warwick , Gibbet Hill Road , Coventry CV4 7AL , UK
| | - Heba A Mohamed
- School of Chemistry , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , UK
| | - Anna K Renfrew
- School of Chemistry , The University of Sydney , Sydney , NSW 2006 , Australia
| | - Peter J Rutledge
- School of Medical Sciences (Discipline of Pharmacology) , University of Sydney , Australia
| | - Peter J Sadler
- Department of Chemistry , University of Warwick , Gibbet Hill Road , Coventry CV4 7AL , UK
| | - Matthew H Todd
- School of Chemistry , The University of Sydney , Sydney , NSW 2006 , Australia
- School of Pharmacy , University College London , London , WC1N 1AX , UK
| | - Charlotte E Willans
- School of Chemistry , University of Leeds , Woodhouse Lane , Leeds LS2 9JT , UK
| | - Justin J Wilson
- Department of Chemistry and Chemical Biology , Cornell University , Ithaca , NY 14853 , USA
| | - Matthew A Cooper
- Centre for Superbug Solutions , Institute for Molecular Bioscience , The University of Queensland , St. Lucia , Queensland 4072 , Australia . ;
| | - Mark A T Blaskovich
- Centre for Superbug Solutions , Institute for Molecular Bioscience , The University of Queensland , St. Lucia , Queensland 4072 , Australia . ;
| |
Collapse
|
14
|
Frei A, Amado M, Cooper MA, Blaskovich MAT. Light-Activated Rhenium Complexes with Dual Mode of Action against Bacteria. Chemistry 2020; 26:2852-2858. [PMID: 31788867 PMCID: PMC7687258 DOI: 10.1002/chem.201904689] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2019] [Revised: 11/12/2019] [Indexed: 12/20/2022]
Abstract
New antibiotics and innovative approaches to kill drug-resistant bacteria are urgently needed. Metal complexes offer access to alternative modes of action but have only sparingly been investigated in antibacterial drug discovery. We have developed a light-activated rhenium complex with activity against drug-resistant S. aureus and E. coli. The activity profile against mutant strains combined with assessments of cellular uptake and synergy suggest two distinct modes of action.
Collapse
Affiliation(s)
- Angelo Frei
- Institute for Molecular BioscienceThe University of QueenslandSt. LuciaQueensland4072Australia
| | - Maite Amado
- Institute for Molecular BioscienceThe University of QueenslandSt. LuciaQueensland4072Australia
| | - Matthew A. Cooper
- Institute for Molecular BioscienceThe University of QueenslandSt. LuciaQueensland4072Australia
| | - Mark A. T. Blaskovich
- Institute for Molecular BioscienceThe University of QueenslandSt. LuciaQueensland4072Australia
| |
Collapse
|
15
|
Frei A. Metal Complexes, an Untapped Source of Antibiotic Potential? Antibiotics (Basel) 2020; 9:E90. [PMID: 32085590 PMCID: PMC7168053 DOI: 10.3390/antibiotics9020090] [Citation(s) in RCA: 98] [Impact Index Per Article: 24.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2020] [Revised: 02/07/2020] [Accepted: 02/12/2020] [Indexed: 01/08/2023] Open
Abstract
With the widespread rise of antimicrobial resistance, most traditional sources for new drug compounds have been explored intensively for new classes of antibiotics. Meanwhile, metal complexes have long had only a niche presence in the medicinal chemistry landscape, despite some compounds, such as the anticancer drug cisplatin, having had a profound impact and still being used extensively in cancer treatments today. Indeed, metal complexes have been largely ignored for antibiotic development. This is surprising as metal compounds have access to unique modes of action and exist in a wider range of three-dimensional geometries than purely organic compounds. These properties make them interesting starting points for the development of new drugs. In this perspective article, , the encouraging work that has been done on antimicrobial metal complexes, mainly over the last decade, is highlighted. Promising metal complexes, their activity profiles, and possible modes of action are discussed and issues that remain to be addressed are emphasized.
Collapse
Affiliation(s)
- Angelo Frei
- Centre for Superbug Solutions, Institute for Molecular Bioscience, The University of Queensland, St Lucia 4072, Australia
| |
Collapse
|
16
|
Abstract
Platinum-group (PG) complexes have been used as antibacterial and anticancer agents since the discovery of cisplatin. The science world still requires improvement on these complexes because of multidrug and antineoplastic resistances. This review observes discoverers and history of these platinum-group metals (PGMs), as well as their beneficial applications. The focus of this study was biological applications of PGMs in relation to human health. Sandwich and half-sandwich PGM coordination compounds and their metal nanoparticles give improved results for biological activities by enhancing efficient delivery of both antibacterial and anticancer drugs, as well as luminescent bioimaging (biomarkers) for biological identifications.
Collapse
|
17
|
|
18
|
Zangoli M, Pugliese M, Monti F, Bergamini G, D’Amone S, Ortolani L, Morandi V, Cortese B, Zanelli A, Gazzano M, Maiorano V, Gigli G, Palamà IE, Maria FD. Nanostructuring Iridium Complexes into Crystalline Phosphorescent Nanoparticles: Structural Characterization, Photophysics, and Biological Applications. ACS APPLIED BIO MATERIALS 2019; 2:4594-4603. [DOI: 10.1021/acsabm.9b00681] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Mattia Zangoli
- CNR-Nanotec, c/o Campus Ecotekne, via Monteroni, 73100 Lecce, Italy
- CNR-ISOF, Via P. Gobetti 101, I-40129 Bologna, Italy
| | - Marco Pugliese
- CNR-Nanotec, c/o Campus Ecotekne, via Monteroni, 73100 Lecce, Italy
- Dipartimento di Matematica e Fisica “E. De Giorgi”, Università del Salento, Via Arnesano snc, 73100 Lecce, Italy
| | - Filippo Monti
- CNR-ISOF, Via P. Gobetti 101, I-40129 Bologna, Italy
| | - Giacomo Bergamini
- Dipartimento di Chimica Giacomo Ciamician, Università di Bologna, Via Selmi 2, I-40126 Bologna, Italy
| | - Stefania D’Amone
- CNR-Nanotec, c/o Campus Ecotekne, via Monteroni, 73100 Lecce, Italy
| | | | | | - Barbara Cortese
- CNR-Nanotec, c/o Dipartimento di Fisica“E. Fermi”, Università La Sapienza, P.zle A. Moro, I-00185 Roma, Italy
| | | | | | | | - Giuseppe Gigli
- CNR-Nanotec, c/o Campus Ecotekne, via Monteroni, 73100 Lecce, Italy
| | | | - Francesca Di Maria
- CNR-Nanotec, c/o Campus Ecotekne, via Monteroni, 73100 Lecce, Italy
- CNR-ISOF, Via P. Gobetti 101, I-40129 Bologna, Italy
| |
Collapse
|
19
|
Smitten KL, Southam HM, de la Serna JB, Gill MR, Jarman PJ, Smythe CGW, Poole RK, Thomas JA. Using Nanoscopy To Probe the Biological Activity of Antimicrobial Leads That Display Potent Activity against Pathogenic, Multidrug Resistant, Gram-Negative Bacteria. ACS NANO 2019; 13:5133-5146. [PMID: 30964642 DOI: 10.1021/acsnano.8b08440] [Citation(s) in RCA: 47] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/27/2023]
Abstract
Medicinal leads that are also compatible with imaging technologies are attractive, as they facilitate the development of therapeutics through direct mechanistic observations at the molecular level. In this context, the uptake and antimicrobial activities of several luminescent dinuclear RuII complexes against E. coli were assessed and compared to results obtained for another ESKAPE pathogen, the Gram-positive major opportunistic pathogen Enterococcus faecalis, V583. The most promising lead displays potent activity, particularly against the Gram-negative bacteria, and potency is retained in the uropathogenic multidrug resistant EC958 ST131 strain. Exploiting the inherent luminescent properties of this complex, super-resolution STED nanoscopy was used to image its initial localization at/in cellular membranes and its subsequent transfer to the cell poles. Membrane damage assays confirm that the complex disrupts the bacterial membrane structure before internalization. Mammalian cell culture and animal model studies indicate that the complex is not toxic to eukaryotes, even at concentrations that are several orders of magnitude higher than its minimum inhibitory concentration (MIC). Taken together, these results have identified a lead molecular architecture for hard-to-treat, multiresistant, Gram-negative bacteria, which displays activities that are already comparable to optimized natural product-based leads.
Collapse
Affiliation(s)
- Kirsty L Smitten
- Department of Chemistry , The University of Sheffield , Western Bank , Sheffield S3 7HF , U.K
| | - Hannah M Southam
- Department of Molecular Biology and Biotechnology , The University of Sheffield , Western Bank , Sheffield S10 2TN , U.K
| | - Jorge Bernardino de la Serna
- Central Laser Facility, Rutherford Appleton Laboratory, Research Complex at Harwell , Science and Technology Facilities Council , Harwell-Oxford , Didcot OX11 0QX , U.K
- Department of Physics , King's College London , London WC2R 2LS , U.K
| | - Martin R Gill
- Department of Chemistry , The University of Sheffield , Western Bank , Sheffield S3 7HF , U.K
| | - Paul J Jarman
- Department of Biomedical Science , The University of Sheffield , Western Bank , Sheffield S10 2TN , U.K
| | - Carl G W Smythe
- Department of Biomedical Science , The University of Sheffield , Western Bank , Sheffield S10 2TN , U.K
| | - Robert K Poole
- Department of Molecular Biology and Biotechnology , The University of Sheffield , Western Bank , Sheffield S10 2TN , U.K
| | - Jim A Thomas
- Department of Chemistry , The University of Sheffield , Western Bank , Sheffield S3 7HF , U.K
| |
Collapse
|
20
|
Wang L, Monro S, Cui P, Yin H, Liu B, Cameron CG, Xu W, Hetu M, Fuller A, Kilina S, McFarland SA, Sun W. Heteroleptic Ir(III)N 6 Complexes with Long-Lived Triplet Excited States and in Vitro Photobiological Activities. ACS APPLIED MATERIALS & INTERFACES 2019; 11:3629-3644. [PMID: 30608121 PMCID: PMC6355354 DOI: 10.1021/acsami.8b14744] [Citation(s) in RCA: 42] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
A series of cationic heteroleptic iridium(III) complexes bearing tris-diimine ligands [Ir(phen)2(R-phen)]3+ (R-phen = phenanthroline (1), 3,8-diphenylphenanthroline (2), 3,8-dipyrenylphenanthroline (3), 3-phenylphenanthroline (4), 3-pyrenylphenanthroline (5), and 3,8-diphenylethynylphenanthroline (6)) were synthesized and characterized. These complexes possessed phen ligand-localized 1π,π* transitions below 300 nm, and charge transfer (1CT) and/or 1π,π* transitions between 300 and 520 nm. In 1, 2, 4, and 6, the low-energy bands were mixed 1CT/1π,π*. However, the increased π-donating ability of the pyrenyl substituent(s) in 3 and 5 split the low-energy bands into a pyrene-based 1π,π* transition at 300-380 nm and an intraligand charge transfer (1ILCT) transition at 380-520 nm. All complexes were emissive at room temperature in CH3CN, but the parentage of the emitting state varied depending on the R substituent(s). Complex 1 exhibited predominantly phen ligand-localized 3π,π* emission mixed with metal-to-ligand charge transfer (3MLCT) character, whereas the emission of 2, 4, and 6 was predominantly from the excited-state with 3π,π*/3ILCT/3MLCT character. The emission from 3 and 5 was dominated by pyrene-based 3π,π* states mixed with 3ILCT character. The different natures of the lowest triplet excited states were also reflected by the different spectral features and lifetimes of the triplet transient absorption of these complexes. Complexes 3 and 5 had singlet oxygen quantum yields as high as 81 and 72%, respectively. Both gave submicromolar phototoxicities toward cancer cells (SK-MEL-28 human melanoma) and bacteria ( S. aureus and S. mutans) with visible-light activation (and marginal to no photobiological activity with red light). Their visible-light phototherapeutic indices (PIs) toward SK-MEL-28 cells were 248 for 3 and >435 for 5; PIs were lower in bacteria (≤62) because of their inherent antimicrobial activities. Both complexes were shown to produce substantial amounts of intracellular reactive oxygen species (ROS), which may account for their photobiological activities.
Collapse
Affiliation(s)
- Li Wang
- Department of Chemistry and Biochemistry, North Dakota State University, Fargo, North Dakota 58108-6050, United States
| | - Susan Monro
- Department of Chemistry, Acadia University, 6 University Avenue, Wolfville, NS B4P 2R6, Canada
| | - Peng Cui
- Department of Chemistry and Biochemistry, North Dakota State University, Fargo, North Dakota 58108-6050, United States
- Materials and Nanotechnology Program, North Dakota State University, Fargo, North Dakota 58108-6050, United States
| | - Huimin Yin
- Department of Chemistry, Acadia University, 6 University Avenue, Wolfville, NS B4P 2R6, Canada
| | - Bingqing Liu
- Department of Chemistry and Biochemistry, North Dakota State University, Fargo, North Dakota 58108-6050, United States
| | - Colin G. Cameron
- Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27402-6170, United States
| | - Wei Xu
- Department of Chemistry and Biochemistry, North Dakota State University, Fargo, North Dakota 58108-6050, United States
| | - Marc Hetu
- Department of Chemistry, Acadia University, 6 University Avenue, Wolfville, NS B4P 2R6, Canada
| | - Anderson Fuller
- Department of Chemistry, Acadia University, 6 University Avenue, Wolfville, NS B4P 2R6, Canada
| | - Svetlana Kilina
- Department of Chemistry and Biochemistry, North Dakota State University, Fargo, North Dakota 58108-6050, United States
| | - Sherri A. McFarland
- Department of Chemistry, Acadia University, 6 University Avenue, Wolfville, NS B4P 2R6, Canada
- Department of Chemistry and Biochemistry, University of North Carolina at Greensboro, Greensboro, North Carolina 27402-6170, United States
| | - Wenfang Sun
- Department of Chemistry and Biochemistry, North Dakota State University, Fargo, North Dakota 58108-6050, United States
| |
Collapse
|
21
|
Sun B, Musgrave IF, Day AI, Heimann K, Keene FR, Collins JG. Eukaryotic Cell Toxicity and HSA Binding of [Ru(Me 4phen)(bb 7)] 2+ and the Effect of Encapsulation in Cucurbit[10]uril. Front Chem 2018; 6:595. [PMID: 30560120 PMCID: PMC6287197 DOI: 10.3389/fchem.2018.00595] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2018] [Accepted: 11/14/2018] [Indexed: 12/12/2022] Open
Abstract
The toxicity (IC50) of a series of mononuclear ruthenium complexes containing bis[4(4′-methyl-2,2′-bipyridyl)]-1,n-alkane (bbn) as a tetradentate ligand against three eukaryotic cell lines—BHK (baby hamster kidney), Caco-2 (heterogeneous human epithelial colorectal adenocarcinoma) and Hep-G2 (liver carcinoma)—have been determined. The results demonstrate that cis-α-[Ru(Me4phen)(bb7)]2+ (designated as α-Me4phen-bb7, where Me4phen = 3,4,7,8-tetramethyl-1,10-phenanthroline) showed little toxicity toward the three cell lines, and was considerably less toxic than cis-α-[Ru(phen)(bb12)]2+ (α-phen-bb12) and the dinuclear complex [{Ru(phen)2}2{μ-bb12}]4+. Fluorescence spectroscopy was used to study the binding of the ruthenium complexes with human serum albumin (HSA). The binding of α-Me4phen-bb7 to the macrocyclic host molecule cucurbit[10]uril (Q[10]) was examined by NMR spectroscopy. Large upfield 1H NMR chemical shift changes observed for the methylene protons in the bb7 ligand upon addition of Q[10], coupled with the observation of several intermolecular ROEs in ROESY spectra, indicated that α-Me4phen-bb7 bound Q[10] with the bb7 methylene carbons within the cavity and the metal center positioned outside one of the portals. Simple molecular modeling confirmed the feasibility of the binding model. An α-Me4phen-bb7-Q[10] binding constant of 9.9 ± 0.2 × 106 M−1 was determined by luminescence spectroscopy. Q[10]-encapsulation decreased the toxicity of α-Me4phen-bb7 against the three eukaryotic cell lines and increased the binding affinity of the ruthenium complex for HSA. Confocal microscopy experiments indicated that the level of accumulation of α-Me4phen-7 in BHK cells is not significantly affected by Q[10]-encapsulation. Taken together, the combined results suggest that α-Me4phen-7 could be a good candidate as a new antimicrobial agent, and Q[10]-encapsulation could be a method to improve the pharmacokinetics of the ruthenium complex.
Collapse
Affiliation(s)
- Biyun Sun
- School of Physical, Environmental and Mathematical Sciences, University of New South Wales, Australian Defence Force Academy, Canberra, ACT, Australia
| | - Ian F Musgrave
- Discipline of Pharmacology, Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia
| | - Anthony I Day
- School of Physical, Environmental and Mathematical Sciences, University of New South Wales, Australian Defence Force Academy, Canberra, ACT, Australia
| | - Kirsten Heimann
- College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.,College of Science and Engineering, James Cook University, Townsville, QLD, Australia
| | - F Richard Keene
- Department of Chemistry, School of Physical Sciences, University of Adelaide, Adelaide, SA, Australia.,Australian Institute of Tropical Health and Medicine/Centre for Molecular Therapeutics, James Cook University, Townsville, QLD, Australia
| | - J Grant Collins
- School of Physical, Environmental and Mathematical Sciences, University of New South Wales, Australian Defence Force Academy, Canberra, ACT, Australia
| |
Collapse
|
22
|
Chen F, Moat J, McFeely D, Clarkson G, Hands-Portman IJ, Furner-Pardoe JP, Harrison F, Dowson CG, Sadler PJ. Biguanide Iridium(III) Complexes with Potent Antimicrobial Activity. J Med Chem 2018; 61:7330-7344. [PMID: 30070838 DOI: 10.1021/acs.jmedchem.8b00906] [Citation(s) in RCA: 57] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
We have synthesized novel organoiridium(III) antimicrobial complexes containing a chelated biguanide, including the antidiabetic drug metformin. These 16- and 18-electron complexes were characterized by NMR, ESI-MS, elemental analysis, and X-ray crystallography. Several of these complexes exhibit potent activity against Gram-negative bacteria and Gram-positive bacteria (including methicillin-resistant Staphylococcus aureus (MRSA)) and high antifungal potency toward C. albicans and C. neoformans, with minimum inhibitory concentrations (MICs) in the nanomolar range. Importantly, the complexes exhibit low cytotoxicity toward mammalian cells, indicating high selectivity. They are highly stable in broth medium, with a low tendency to generate resistance mutations. On coadministration, they can restore the activity of vancomycin against vancomycin-resistant Enterococci (VRE). Also the complexes can disrupt and eradicate bacteria in mature biofilms. Investigations of reactions with biomolecules suggest that these organometallic complexes deliver active biguanides into microorganisms, whereas the biguanides themselves are inactive when administered alone.
Collapse
|
23
|
|
24
|
Sun B, Southam HM, Butler JA, Poole RK, Burgun A, Tarzia A, Keene FR, Collins JG. Synthesis, isomerisation and biological properties of mononuclear ruthenium complexes containing the bis[4(4'-methyl-2,2'-bipyridyl)]-1,7-heptane ligand. Dalton Trans 2018; 47:2422-2434. [PMID: 29379923 DOI: 10.1039/c7dt04595f] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
A series of mononuclear ruthenium(ii) complexes containing the tetradentate ligand bis[4(4'-methyl-2,2'-bipyridyl)]-1,7-heptane have been synthesised and their biological properties examined. In the synthesis of the [Ru(phen')(bb7)]2+ complexes (where phen' = 1,10-phenanthroline and its 5-nitro-, 4,7-dimethyl- and 3,4,7,8-tetramethyl- derivatives), both the symmetric cis-α and non-symmetric cis-β isomers were formed. However, upon standing for a number of days (or more quickly under harsh conditions) the cis-β isomer converted to the more thermodynamically stable cis-α isomer. The minimum inhibitory concentrations (MIC) and the minimum bactericidal concentrations (MBC) of the ruthenium(ii) complexes were determined against six strains of bacteria: Gram-positive Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA); and the Gram-negative Escherichia coli (E. coli) strains MG1655, APEC, UPEC and Pseudomonas aeruginosa (P. aeruginosa). The results showed that the [Ru(5-NO2phen)(bb7)]2+ complex had little or no activity against any of the bacterial strains. By contrast, for the other cis-α-[Ru(phen')(bb7)]2+ complexes, the antimicrobial activity increased with the degree of methylation. In particular, the cis-α-[Ru(Me4phen)(bb7)]2+ complex showed excellent and uniform MIC activity against all bacteria. By contrast, the MBC values for the cis-α-[Ru(Me4phen)(bb7)]2+ complex varied considerably across the bacteria and even within S. aureus and E. coli strains. In order to gain an understanding of the relative antimicrobial activities, the DNA-binding affinity, cellular accumulation and water-octanol partition coefficients (log P) of the ruthenium complexes were determined. Interestingly, all the [Ru(phen')(bb7)]2+ complexes exhibited stronger DNA binding affinity (Ka ≈ 1 × 107 M-1) than the well-known DNA-intercalating complex [Ru(phen)2(dppz)]2+ (where dppz = dipyrido[3,2-a:2',3'-c]phenazine).
Collapse
Affiliation(s)
- Biyun Sun
- School of Physical, Environmental and Mathematical Sciences, University of New South Wales, Australian Defence Force Academy, Canberra, ACT 2600, Australia.
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Catalytic Water Oxidation by Iridium-Modified Carbonic Anhydrase. Chem Asian J 2018; 13:334-341. [DOI: 10.1002/asia.201701543] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2017] [Revised: 12/24/2017] [Indexed: 11/07/2022]
|
26
|
Sundaraneedi MK, Tedla BA, Eichenberger RM, Becker L, Pickering D, Smout MJ, Rajan S, Wangchuk P, Keene FR, Loukas A, Collins JG, Pearson MS. Polypyridylruthenium(II) complexes exert anti-schistosome activity and inhibit parasite acetylcholinesterases. PLoS Negl Trop Dis 2017; 11:e0006134. [PMID: 29240773 PMCID: PMC5746282 DOI: 10.1371/journal.pntd.0006134] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2017] [Revised: 12/28/2017] [Accepted: 11/23/2017] [Indexed: 12/22/2022] Open
Abstract
BACKGROUND Schistosomiasis affects over 200 million people and there are concerns whether the current chemotherapeutic control strategy (periodic mass drug administration with praziquantel (PZQ)-the only licenced anti-schistosome compound) is sustainable, necessitating the development of new drugs. METHODOLOGY/PRINCIPAL FINDINGS We investigated the anti-schistosome efficacy of polypyridylruthenium(II) complexes and showed they were active against all intra-mammalian stages of S. mansoni. Two compounds, Rubb12-tri and Rubb7-tnl, which were among the most potent in their ability to kill schistosomula and adult worms and inhibit egg hatching in vitro, were assessed for their efficacy in a mouse model of schistosomiasis using 5 consecutive daily i.v. doses of 2 mg/kg (Rubb12-tri) and 10 mg/kg (Rubb7-tnl). Mice treated with Rubb12-tri showed an average 42% reduction (P = 0.009), over two independent trials, in adult worm burden. Liver egg burdens were not significantly decreased in either drug-treated group but ova from both of these groups showed significant decreases in hatching ability (Rubb12-tri-68%, Rubb7-tnl-56%) and were significantly morphologically altered (Rubb12-tri-62% abnormal, Rubb7-tnl-35% abnormal). We hypothesize that the drugs exerted their activity, at least partially, through inhibition of both neuronal and tegumental acetylcholinesterases (AChEs), as worms treated in vitro showed significant decreases in activity of these enzymes. Further, treated parasites exhibited a significantly decreased ability to uptake glucose, significantly depleted glycogen stores and withered tubercules (a site of glycogen storage), implying drug-mediated interference in this nutrient acquisition pathway. CONCLUSIONS/SIGNIFICANCE Our data provide compelling evidence that ruthenium complexes are effective against all intra-mammalian stages of schistosomes, including schistosomula (refractory to PZQ) and eggs (agents of disease transmissibility). Further, the results of this study suggest that schistosome AChE is a target of ruthenium drugs, a finding that can inform modification of current compounds to identify analogues which are even more effective and selective against schistosomes.
Collapse
Affiliation(s)
- Madhu K. Sundaraneedi
- School of Physical, Environmental and Mathematical Sciences, UNSW Canberra, Canberra, Australian Capital Territory, Australia
| | - Bemnet A. Tedla
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia
| | - Ramon M. Eichenberger
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia
| | - Luke Becker
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia
| | - Darren Pickering
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia
| | - Michael J. Smout
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia
| | - Siji Rajan
- School of Physical, Environmental and Mathematical Sciences, UNSW Canberra, Canberra, Australian Capital Territory, Australia
| | - Phurpa Wangchuk
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia
| | - F. Richard Keene
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia
- School of Physical Sciences, University of Adelaide, Adelaide, South Australia, Australia
| | - Alex Loukas
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia
| | - J. Grant Collins
- School of Physical, Environmental and Mathematical Sciences, UNSW Canberra, Canberra, Australian Capital Territory, Australia
| | - Mark S. Pearson
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, Australia
| |
Collapse
|
27
|
Sundaraneedi M, Eichenberger RM, Al-Hallaf R, Yang D, Sotillo J, Rajan S, Wangchuk P, Giacomin PR, Keene FR, Loukas A, Collins JG, Pearson MS. Polypyridylruthenium(II) complexes exert in vitro and in vivo nematocidal activity and show significant inhibition of parasite acetylcholinesterases. INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE 2017; 8:1-7. [PMID: 29207309 PMCID: PMC5724747 DOI: 10.1016/j.ijpddr.2017.11.005] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/12/2017] [Revised: 11/23/2017] [Accepted: 11/27/2017] [Indexed: 12/28/2022]
Abstract
Over 4.5 billion people are at risk of infection with soil transmitted helminths and there are concerns about the development of resistance to the handful of frontline nematocides in endemic populations. We investigated the anti-nematode efficacy of a series of polypyridylruthenium(II) complexes and showed they were active against L3 and adult stages of Trichuris muris, the rodent homologue of the causative agent of human trichuriasis, T. trichiura. One of the compounds, Rubb12-mono, which was among the most potent in its ability to kill L3 (IC50 = 3.1 ± 0.4 μM) and adult (IC50 = 5.2 ± 0.3 μM) stage worms was assessed for efficacy in a mouse model of trichuriasis by administering 3 consecutive daily oral doses of the drug 3 weeks post infection with the murine whipworm Trichuris muris. Mice treated with Rubb12-mono showed an average 66% reduction (P = 0.015) in faecal egg count over two independent trials. The drugs partially exerted their activity through inhibition of acetylcholinesterases, as worms treated in vitro and in vivo showed significant decreases in the activity of this class of enzymes. Our data show that ruthenium complexes are effective against T. muris, a model gastro-intestinal nematode and soil-transmitted helminth. Further, knowledge of the target of ruthenium drugs can facilitate modification of current compounds to identify analogues which are even more effective and selective against Trichuris and other helminths of human and veterinary importance. The effect of ruthenium complexes on Trichuris muris parasites were investigated. The drugs killed L3 and adult worms in vitro at low micromolar concentrations. The compounds partially exerted activity through acetylcholinesterase inhibition. When given to infected mice, Rubb12-mono significantly reduced parasite burden.
Collapse
Affiliation(s)
- Madhu Sundaraneedi
- School of Physical, Environmental and Mathematical Sciences, UNSW (ADFA), Canberra, Australian Capital Territory, 2612, Australia
| | - Ramon M Eichenberger
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, 4878, Australia
| | - Rafid Al-Hallaf
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, 4878, Australia
| | - Dai Yang
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, 4878, Australia
| | - Javier Sotillo
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, 4878, Australia
| | - Siji Rajan
- School of Physical, Environmental and Mathematical Sciences, UNSW (ADFA), Canberra, Australian Capital Territory, 2612, Australia
| | - Phurpa Wangchuk
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, 4878, Australia
| | - Paul R Giacomin
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, 4878, Australia
| | - F Richard Keene
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, 4878, Australia; School of Physical Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia
| | - Alex Loukas
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, 4878, Australia
| | - J Grant Collins
- School of Physical, Environmental and Mathematical Sciences, UNSW (ADFA), Canberra, Australian Capital Territory, 2612, Australia
| | - Mark S Pearson
- Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland, 4878, Australia.
| |
Collapse
|
28
|
Sun W, Sun S, Jiang N, Gao L, Zheng G. Study of highly efficient heterodinuclear Ir-Os ECL complexes. J Organomet Chem 2017. [DOI: 10.1016/j.jorganchem.2017.07.014] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
29
|
Syntheses, crystal structures and DNA-binding activities of divalent Fe, Cu, Zn and Cd complexes with 4′-(furan-2-yl)-2,2′:6′,2″-terpyridine. ZEITSCHRIFT FUR NATURFORSCHUNG SECTION B-A JOURNAL OF CHEMICAL SCIENCES 2017. [DOI: 10.1515/znb-2017-0041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
Five coordination complexes [Fe(ftpy)2](ClO4)2·(H2O)2 (1), [Cu(ftpy)(NO3)(H2O)](NO3) (2), [Cu(ftpy)2]2(ClO4)4·(C2H5OH) (3), [Zn(ftpy)2]·(ClO4)2·(H2O)1.5 (4) and [Cd(ftpy)2]2(ClO4)4·(C2H5OH) (5) (ftpy=4′-(furan-2-yl)-2,2′:6′,2′-terpyridine) have been synthesized and characterized by IR, elemental analysis and single-crystal X-ray diffraction. With the exception of 4, all complexes adopt normal homoleptic [M(ftpy)2]2+ motifs. In the crystal, both hydrogen bonds and face-to-face interactions between furyl and pyridyl rings facilitate the construction of three-dimensional networks. The DNA-binding activities of the five complexes have been investigated by fluorescence emission titration at room temperature suggesting an intercalative mode for 1–3 with a relative order, 3>2>1, and a combined static and dynamic mode for 4 and 5.
Collapse
|
30
|
Fiorini V, Zanoni I, Zacchini S, Costa AL, Hochkoeppler A, Zanotti V, Ranieri AM, Massi M, Stefan A, Stagni S. Methylation of Ir(iii)-tetrazolato complexes: an effective route to modulate the emission outputs and to switch to antimicrobial properties. Dalton Trans 2017; 46:12328-12338. [PMID: 28891573 DOI: 10.1039/c7dt02352a] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Two neutral cyclometalated Ir(iii)-tetrazolato complexes that differ by variations of the substituents on either the phenylpyridine or the tetrazolate ligand have been converted into the corresponding methylated and cationic analogues. NMR (1H and 13C) characterization of the Ir(iii) complexes provided the results in agreement with the chemo- and regioselective character of methylation at the N-3 position of the Ir(iii)-coordinated tetrazolato ring. This evidence was further corroborated by the analysis of the molecular structures of the cationic complexes obtained by X-ray diffraction. In view of the photophysical properties, the addition of a methyl moiety to neutral Ir(iii) tetrazolates, which behave as sky-blue or orange phosphors, caused a systematic red shift of their phosphorescence output. The transformation of neutral Ir(iii) tetrazolates into cationic Ir(iii)-tetrazole complexes was screened for any eventual antimicrobial activity in vitro against Gram negative (E. coli) and Gram positive (D. radiodurans) microorganisms. While both kinds of complexes were not active against E. coli, the conversion of the neutral Ir(iii) tetrazolates into the corresponding methylated and cationic Ir(iii)tetrazole derivatives determined the turn-on of a good to excellent antimicrobial activity toward Gram positive Deinococcus radiodurans, a non-pathogenic bacterium that is listed as one of the toughest microorganisms in light of its outstanding resistance to radiation and oxidative stress.
Collapse
Affiliation(s)
- Valentina Fiorini
- Department of Industrial Chemistry "Toso Montanari", University of Bologna, Viale Risorgimento 4, I-40136 Bologna, Italy.
| | - Ilaria Zanoni
- Department of Industrial Chemistry "Toso Montanari", University of Bologna, Viale Risorgimento 4, I-40136 Bologna, Italy. and CNR-ISTEC-National Research Council of Italy, Institute of Science and Technology for Ceramics, Via Granarolo 64 I-48018, Faenza, RA, Italy
| | - Stefano Zacchini
- Department of Industrial Chemistry "Toso Montanari", University of Bologna, Viale Risorgimento 4, I-40136 Bologna, Italy.
| | - Anna Luisa Costa
- CNR-ISTEC-National Research Council of Italy, Institute of Science and Technology for Ceramics, Via Granarolo 64 I-48018, Faenza, RA, Italy
| | - Alejandro Hochkoeppler
- Department of Pharmacy and Biotechnology, University of Bologna, Viale Risorgimento 4, I-40136 Bologna, Italy. and CSGI, University of Florence, Via della Lastruccia 3, 50019 Sesto Fiorentino, FI, Italy
| | - Valerio Zanotti
- Department of Industrial Chemistry "Toso Montanari", University of Bologna, Viale Risorgimento 4, I-40136 Bologna, Italy.
| | - Anna Maria Ranieri
- Nanochemistry Research Institute, Department of Chemistry, Curtin University, GPO Box U 1987, Perth, Australia 6845.
| | - Massimiliano Massi
- Nanochemistry Research Institute, Department of Chemistry, Curtin University, GPO Box U 1987, Perth, Australia 6845.
| | - Alessandra Stefan
- Department of Pharmacy and Biotechnology, University of Bologna, Viale Risorgimento 4, I-40136 Bologna, Italy. and CSGI, University of Florence, Via della Lastruccia 3, 50019 Sesto Fiorentino, FI, Italy
| | - Stefano Stagni
- Department of Industrial Chemistry "Toso Montanari", University of Bologna, Viale Risorgimento 4, I-40136 Bologna, Italy.
| |
Collapse
|
31
|
Abstract
Ruthenium is seldom mentioned in microbiology texts, due to the fact that this metal has no known, essential roles in biological systems, nor is it generally considered toxic. Since the fortuitous discovery of cisplatin, first as an antimicrobial agent and then later employed widely as an anticancer agent, complexes of other platinum group metals, such as ruthenium, have attracted interest for their medicinal properties. Here, we review at length how ruthenium complexes have been investigated as potential antimicrobial, antiparasitic and chemotherapeutic agents, in addition to their long and well-established roles as biological stains and inhibitors of calcium channels. Ruthenium complexes are also employed in a surprising number of biotechnological roles. It is in the employment of ruthenium complexes as antimicrobial agents and alternatives or adjuvants to more traditional antibiotics, that we expect to see the most striking developments in the future. Such novel contributions from organometallic chemistry are undoubtedly sorely needed to address the antimicrobial resistance crisis and the slow appearance on the market of new antibiotics.
Collapse
|
32
|
Vasdev RAS, Preston D, Scottwell SØ, Brooks HJL, Crowley JD, Schramm MP. Oxidatively Locked [Co₂L₃] 6+ Cylinders Derived from Bis(bidentate) 2-Pyridyl-1,2,3-triazole "Click" Ligands: Synthesis, Stability, and Antimicrobial Studies. Molecules 2016; 21:E1548. [PMID: 27854348 PMCID: PMC6273053 DOI: 10.3390/molecules21111548] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2016] [Revised: 11/04/2016] [Accepted: 11/10/2016] [Indexed: 11/17/2022] Open
Abstract
A small family of [Co₂(Lpytrz)₃]6+ cylinders was synthesised from bis(bidentate) 2-pyridyl-1,2,3-triazole "click" ligands (Lpytrz) through an "assembly-followed-by-oxidation" method. The cylinders were characterised using ¹H, 13C, and DOSY NMR, IR, and UV-Vis spectroscopies, along with electrospray ionisation mass spectrometry (ESMS). Stability studies were conducted in dimethyl sulfoxide (DMSO) and D₂O. In contrast to similar, previously studied, [Fe₂(Lpytrz)₃]4+ helicates the more kinetically inert [Co₂(Lpytrz)₃]6+ systems proved stable (over a period of days) when exposed to DMSO and were even more stable in D₂O. The triply stranded [Co₂(Lpytrz)₃]6+ systems and the corresponding "free" ligands were tested for antimicrobial activity in vitro against both Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) microorganisms. Agar-based disk diffusion and Mueller-Hinton broth micro-dilution assays showed that the [Co₂(Lpytrz)₃]6+ cylinders were not active against either strain of bacteria. It is presumed that a high charge of the [Co₂(Lpytrz)₃]6+ cylinders is preventing them from crossing the bacterial cell membranes, rendering the compounds biologically inactive.
Collapse
Affiliation(s)
- Roan A S Vasdev
- Department of Chemistry, University of Otago, P.O. Box 56, Dunedin 9016, Otago, New Zealand.
| | - Dan Preston
- Department of Chemistry, University of Otago, P.O. Box 56, Dunedin 9016, Otago, New Zealand.
| | - Synøve Ø Scottwell
- Department of Chemistry, University of Otago, P.O. Box 56, Dunedin 9016, Otago, New Zealand.
| | - Heather J L Brooks
- Department of Microbiology and Immunology, University of Otago, P.O. Box 56, 720 Cumberland Street, Dunedin 9054, Otago, New Zealand.
| | - James D Crowley
- Department of Chemistry, University of Otago, P.O. Box 56, Dunedin 9016, Otago, New Zealand.
| | - Michael P Schramm
- Department of Chemistry and Biochemistry, California State University, Long Beach, 1250 Bellflower Boulevard, Long Beach, CA 90840-9507, USA.
| |
Collapse
|
33
|
Weber DK, Sani MA, Downton MT, Separovic F, Keene FR, Collins JG. Membrane Insertion of a Dinuclear Polypyridylruthenium(II) Complex Revealed by Solid-State NMR and Molecular Dynamics Simulation: Implications for Selective Antibacterial Activity. J Am Chem Soc 2016; 138:15267-15277. [DOI: 10.1021/jacs.6b09996] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Affiliation(s)
- Daniel K. Weber
- Computational
Biophysics, IBM Research Australia, Melbourne, VIC 3010, Australia
- School
of Chemistry, Bio21 Institute, University of Melbourne, Parkville, VIC 3010, Australia
| | - Marc-Antoine Sani
- School
of Chemistry, Bio21 Institute, University of Melbourne, Parkville, VIC 3010, Australia
| | - Matthew T. Downton
- Computational
Biophysics, IBM Research Australia, Melbourne, VIC 3010, Australia
- School
of Chemistry, Bio21 Institute, University of Melbourne, Parkville, VIC 3010, Australia
| | - Frances Separovic
- School
of Chemistry, Bio21 Institute, University of Melbourne, Parkville, VIC 3010, Australia
| | - F. Richard Keene
- School
of Physical Sciences, University of Adelaide, Adelaide, SA 5005, Australia
- Centre for Biodiscovery & Molecular Development of Therapeutics, James Cook University, Townsville, QLD 4811, Australia
| | - J. Grant Collins
- School
of Physical, Environmental and Mathematical Sciences, University of New South Wales, Australian Defence Force Academy, Canberra, ACT 2600, Australia
| |
Collapse
|
34
|
Kumar SV, Scottwell SØ, Waugh E, McAdam CJ, Hanton LR, Brooks HJL, Crowley JD. Antimicrobial Properties of Tris(homoleptic) Ruthenium(II) 2-Pyridyl-1,2,3-triazole “Click” Complexes against Pathogenic Bacteria, Including Methicillin-Resistant Staphylococcus aureus (MRSA). Inorg Chem 2016; 55:9767-9777. [DOI: 10.1021/acs.inorgchem.6b01574] [Citation(s) in RCA: 57] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Affiliation(s)
- Sreedhar V. Kumar
- Department
of Chemistry, University of Otago, PO Box 56, Dunedin, New Zealand
- Department
of Microbiology and Immunology, Otago School of Medical Sciences, University of Otago, PO Box 56, Dunedin, New Zealand
| | - Synøve Ø. Scottwell
- Department
of Chemistry, University of Otago, PO Box 56, Dunedin, New Zealand
- Department
of Microbiology and Immunology, Otago School of Medical Sciences, University of Otago, PO Box 56, Dunedin, New Zealand
| | - Emily Waugh
- Department
of Microbiology and Immunology, Otago School of Medical Sciences, University of Otago, PO Box 56, Dunedin, New Zealand
| | - C. John McAdam
- Department
of Chemistry, University of Otago, PO Box 56, Dunedin, New Zealand
| | - Lyall R. Hanton
- Department
of Chemistry, University of Otago, PO Box 56, Dunedin, New Zealand
| | - Heather J. L. Brooks
- Department
of Microbiology and Immunology, Otago School of Medical Sciences, University of Otago, PO Box 56, Dunedin, New Zealand
| | - James D. Crowley
- Department
of Chemistry, University of Otago, PO Box 56, Dunedin, New Zealand
| |
Collapse
|
35
|
Baschieri A, Monti F, Matteucci E, Mazzanti A, Barbieri A, Armaroli N, Sambri L. A Mesoionic Carbene as Neutral Ligand for Phosphorescent Cationic Ir(III) Complexes. Inorg Chem 2016; 55:7912-9. [PMID: 27483041 DOI: 10.1021/acs.inorgchem.6b00869] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Two phosphorescent Ir(III) complexes bearing a mesoionic carbene ligand based on 1,2,3-triazolylidene are obtained for the first time. A silver-iridium transmetalation of the in situ-generated mesoionic carbene affords the cationic dichloro complex [Ir(trizpy)2Cl2](+) (3, trizpy = 1-benzyl-3-methyl-4-(pyridin-2-yl)-1H-1,2,3-triazolylidene) that reacts with a bis-tetrazolate (b-trz) dianionic ligand to give [Ir(trizpy)2(b-trz)](+) (5). The new compounds are fully characterized by NMR spectroscopy and mass spectrometry, and the X-ray structure of 3 is determined. The electrochemical behavior is somewhat different compared to most standard cationic iridium complexes. The first oxidation process is shifted to substantially higher potential in both 3 and 5, due to peculiar and different ligand-induced effects in the two cases, which stabilize the highest occupied molecular orbital; reduction processes are centered on the mesoionic carbene ligands. Both compounds exhibit a mostly ligand-centered luminescence band in the blue-green spectral region, substantially stronger in the case of 5 versus 3, both in CH3CN solution and in poly(methyl methacrylate) matrix at room temperature. Optimized geometries, orbital energies, spin densities, and electronic transitions are determined via density functional theory calculations, which support a full rationalization of the electrochemical and photophysical behavior. This work paves the way for the development of Ir-based emitters with neutral mesoionic carbene ligands and anionic ancillary ligands, a new concept in the area of cationic Ir(III) complexes.
Collapse
Affiliation(s)
- Andrea Baschieri
- Dipartimento di Chimica Industriale "Toso Montanari", Università di Bologna , Viale Risorgimento 4, I-40136 Bologna, Italy
| | - Filippo Monti
- Istituto per la Sintesi Organica e la Fotoreattività, Consiglio Nazionale delle Ricerche , Via P. Gobetti 101, I-40129 Bologna, Italy
| | - Elia Matteucci
- Dipartimento di Chimica Industriale "Toso Montanari", Università di Bologna , Viale Risorgimento 4, I-40136 Bologna, Italy
| | - Andrea Mazzanti
- Dipartimento di Chimica Industriale "Toso Montanari", Università di Bologna , Viale Risorgimento 4, I-40136 Bologna, Italy
| | - Andrea Barbieri
- Istituto per la Sintesi Organica e la Fotoreattività, Consiglio Nazionale delle Ricerche , Via P. Gobetti 101, I-40129 Bologna, Italy
| | - Nicola Armaroli
- Istituto per la Sintesi Organica e la Fotoreattività, Consiglio Nazionale delle Ricerche , Via P. Gobetti 101, I-40129 Bologna, Italy
| | - Letizia Sambri
- Dipartimento di Chimica Industriale "Toso Montanari", Università di Bologna , Viale Risorgimento 4, I-40136 Bologna, Italy
| |
Collapse
|
36
|
Gorle AK, Li X, Primrose S, Li F, Feterl M, Kinobe RT, Heimann K, Warner JM, Keene FR, Collins JG. Oligonuclear polypyridylruthenium(II) complexes: selectivity between bacteria and eukaryotic cells. J Antimicrob Chemother 2016; 71:1547-55. [PMID: 26945708 DOI: 10.1093/jac/dkw026] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2015] [Accepted: 01/25/2016] [Indexed: 12/28/2022] Open
Abstract
OBJECTIVES The objectives of this study were to: (i) determine the in vitro activities of a series of di-, tri- and tetra-nuclear ruthenium complexes (Rubbn, Rubbn-tri and Rubbn-tetra) against a range of Gram-positive and -negative bacteria and compare the antimicrobial activities with the corresponding toxicities against eukaryotic cells; and (ii) compare MIC values with achievable in vivo serum concentrations for the least toxic ruthenium complex. METHODS The in vitro activities were determined by MIC assays and time-kill curve experiments, while the toxicities of the ruthenium complexes were determined using the Alamar blue cytotoxicity assay. A preliminary pharmacokinetic study was undertaken to determine the Rubb12 serum concentration in mice as a function of time after administration. RESULTS Rubb12, Rubb12-tri and Rubb12-tetra are highly active, with MIC values of 1-2 mg/L (0.5-1.5 μM) for a range of Gram-positive strains, but showed variable activities against a panel of Gram-negative bacteria. Time-kill experiments indicated that Rubb12, Rubb12-tri and Rubb12-tetra are bactericidal and kill bacteria within 3-8 h. The di-, tri- and tetra-nuclear complexes were ∼50 times more toxic to Gram-positive bacteria and 25 times more toxic to Gram-negative strains, classified as susceptible, than to liver and kidney cells. Preliminary pharmacokinetic experiments established that serum concentrations higher than MIC values can be obtained for Rubb12 with an administered dose of 32 mg/kg. CONCLUSIONS The ruthenium complexes, particularly Rubb12, have potential as new antimicrobial agents. The structure of the dinuclear ruthenium complex can be readily further modified in order to increase the selectivity for bacteria over eukaryotic cells.
Collapse
Affiliation(s)
- Anil K Gorle
- School of Physical, Environmental and Mathematical Sciences, University of New South Wales, Australian Defence Force Academy, Canberra, ACT 2600, Australia
| | - Xin Li
- School of Physical, Environmental and Mathematical Sciences, University of New South Wales, Australian Defence Force Academy, Canberra, ACT 2600, Australia
| | - Sebastian Primrose
- College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, QLD 4811, Australia Centre for Biodiscovery and Molecular Development of Therapeutics, James Cook University, Townsville, QLD 4811, Australia
| | - Fangfei Li
- School of Physical, Environmental and Mathematical Sciences, University of New South Wales, Australian Defence Force Academy, Canberra, ACT 2600, Australia
| | - Marshall Feterl
- College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, QLD 4811, Australia Centre for Biodiscovery and Molecular Development of Therapeutics, James Cook University, Townsville, QLD 4811, Australia
| | - Robert T Kinobe
- College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, QLD 4811, Australia Centre for Biodiscovery and Molecular Development of Therapeutics, James Cook University, Townsville, QLD 4811, Australia
| | - Kirsten Heimann
- Centre for Biodiscovery and Molecular Development of Therapeutics, James Cook University, Townsville, QLD 4811, Australia College of Marine & Environmental Sciences, James Cook University, Townsville, QLD 4811, Australia
| | - Jeffrey M Warner
- College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, QLD 4811, Australia Centre for Biodiscovery and Molecular Development of Therapeutics, James Cook University, Townsville, QLD 4811, Australia
| | - F Richard Keene
- Centre for Biodiscovery and Molecular Development of Therapeutics, James Cook University, Townsville, QLD 4811, Australia College of Science, Technology and Engineering, James Cook University, Townsville, QLD 4811, Australia School of Physical Sciences, University of Adelaide, Adelaide, SA 5000, Australia
| | - J Grant Collins
- School of Physical, Environmental and Mathematical Sciences, University of New South Wales, Australian Defence Force Academy, Canberra, ACT 2600, Australia
| |
Collapse
|
37
|
Synthesis, characterisation, cytotoxicity and antibacterial activity of ruthenium(II) and rhodium(III) complexes with sulfur-containing terpyridines. Polyhedron 2016. [DOI: 10.1016/j.poly.2015.12.059] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
38
|
Li X, Heimann K, Li F, Warner JM, Richard Keene F, Grant Collins J. Dinuclear ruthenium(ii) complexes containing one inert metal centre and one coordinatively-labile metal centre: syntheses and biological activities. Dalton Trans 2016; 45:4017-29. [DOI: 10.1039/c5dt04885k] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Dinuclear ruthenium(ii) complexes containing one inert and one labile metal centre have been synthesised and their biological properties examined in bacterial and eukaryotic cells.
Collapse
Affiliation(s)
- Xin Li
- School of Physical
- Environmental and Mathematical Sciences
- University of New South Wales
- Australian Defence Force Academy
- Canberra
| | - Kirsten Heimann
- College of Marine & Environmental Sciences
- James Cook University
- Townsville
- Australia
- Centre for Biodiscovery and Molecular Development of Therapeutics
| | - Fangfei Li
- School of Physical
- Environmental and Mathematical Sciences
- University of New South Wales
- Australian Defence Force Academy
- Canberra
| | - Jeffrey M. Warner
- Centre for Biodiscovery and Molecular Development of Therapeutics
- James Cook University
- Townsville
- Australia
- College of Public Health
| | - F. Richard Keene
- Centre for Biodiscovery and Molecular Development of Therapeutics
- James Cook University
- Townsville
- Australia
- College of Science
| | - J. Grant Collins
- School of Physical
- Environmental and Mathematical Sciences
- University of New South Wales
- Australian Defence Force Academy
- Canberra
| |
Collapse
|
39
|
Abstract
One of the major advances in medical science has been the development of antimicrobials; however, a consequence of their widespread use has been the emergence of drug-resistant populations of microorganisms. There is clearly a need for the development of new antimicrobials--but more importantly, there is the need for the development of new classes of antimicrobials, rather than drugs based upon analogues of known scaffolds. Due to the success of the platinum anticancer agents, there has been considerable interest in the development of therapeutic agents based upon other transition metals--and in particular ruthenium(II/III) complexes, due to their well known interaction with DNA. There have been many studies of the anticancer properties and cellular localisation of a range of ruthenium complexes in eukaryotic cells over the last decade. However, only very recently has there been significant interest in their antimicrobial properties. This review highlights the types of ruthenium complexes that have exhibited significant antimicrobial activity and discusses the relationship between chemical structure and biological processing--including site(s) of intracellular accumulation--of the ruthenium complexes in both bacterial and eukaryotic cells.
Collapse
Affiliation(s)
- Fangfei Li
- School of Physical, Environmental and Mathematical Sciences, University of New South Wales, Australian Defence Force Academy, Canberra, ACT 2600, Australia.
| | | | | |
Collapse
|
40
|
Pandrala M, Sundaraneedi MK, Ammit AJ, Woodward CE, Wallace L, Keene FR, Collins JG. Differential Anticancer Activities of the Geometric Isomers of Dinuclear Iridium(III) Complexes. Eur J Inorg Chem 2015. [DOI: 10.1002/ejic.201501069] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
|
41
|
Abd-El-Aziz AS, Agatemor C, Etkin N, Overy DP, Lanteigne M, McQuillan K, Kerr RG. Antimicrobial Organometallic Dendrimers with Tunable Activity against Multidrug-Resistant Bacteria. Biomacromolecules 2015; 16:3694-703. [DOI: 10.1021/acs.biomac.5b01207] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Alaa S. Abd-El-Aziz
- Department
of Chemistry, University of Prince Edward Island, 550 University
Avenue, Charlottetown, Prince
Edward Island C1A 4P3, Canada
| | - Christian Agatemor
- Department
of Chemistry, University of Prince Edward Island, 550 University
Avenue, Charlottetown, Prince
Edward Island C1A 4P3, Canada
| | - Nola Etkin
- Department
of Chemistry, University of Prince Edward Island, 550 University
Avenue, Charlottetown, Prince
Edward Island C1A 4P3, Canada
| | - David P. Overy
- Department
of Chemistry, University of Prince Edward Island, 550 University
Avenue, Charlottetown, Prince
Edward Island C1A 4P3, Canada
- Department
of Pathology and Microbiology, Atlantic Veterinary College, University of Prince Edward Island, 550 University Avenue, Charlottetown, Prince Edward Island C1A 4P3, Canada
| | - Martin Lanteigne
- Department
of Chemistry, University of Prince Edward Island, 550 University
Avenue, Charlottetown, Prince
Edward Island C1A 4P3, Canada
| | - Katherine McQuillan
- Department
of Chemistry, University of Prince Edward Island, 550 University
Avenue, Charlottetown, Prince
Edward Island C1A 4P3, Canada
| | - Russell G. Kerr
- Department
of Chemistry, University of Prince Edward Island, 550 University
Avenue, Charlottetown, Prince
Edward Island C1A 4P3, Canada
- Department
of Biomedical Sciences, Atlantic Veterinary College, University of Prince Edward Island, 550 University Avenue, Charlottetown, Prince Edward Island C1A 4P3, Canada
| |
Collapse
|
42
|
Nyawade EA, Friedrich HB, Omondi B, Mpungose P. Synthesis and Characterization of New (η5-Cyclopentadienyl)dicarbonylruthenium(II) Amine Complexes: Their Application as Homogeneous Catalysts in Styrene Oxidation. Organometallics 2015. [DOI: 10.1021/acs.organomet.5b00564] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Eunice A. Nyawade
- School of Chemistry and Physics, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa
| | - Holger B. Friedrich
- School of Chemistry and Physics, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa
| | - Bernard Omondi
- School of Chemistry and Physics, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa
| | - Philani Mpungose
- School of Chemistry and Physics, University of KwaZulu-Natal, Private Bag X54001, Durban 4000, South Africa
| |
Collapse
|
43
|
Identification of an iridium(III) complex with anti-bacterial and anti-cancer activity. Sci Rep 2015; 5:14544. [PMID: 26416333 PMCID: PMC4586517 DOI: 10.1038/srep14544] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2015] [Accepted: 06/03/2015] [Indexed: 12/25/2022] Open
Abstract
Group 9 transition metal complexes have been widely explored as therapeutic agents due to their unique geometry, their propensity to undergo ligand exchanges with biomolecules and their diverse steric and electronic properties. These metal complexes can offer distinct modes of action in living organisms compared to carbon-based molecules. In this study, we investigated the antimicrobial and anti-proliferative abilities of a series of cyclometallated iridium(III) complexes. The iridium(III) complex 1 inhibited the growth of S. aureus with MIC and MBC values of 3.60 and 7.19 μM, respectively, indicating its potent bactericidal activity. Moreover, complex 1 also exhibited cytotoxicity against a number of cancer cell lines, with particular potency against ovarian, cervical and melanoma cells. This cyclometallated iridium(III) complex is the first example of a substitutionally-inert, Group 9 organometallic compound utilized as a direct and selective inhibitor of S. aureus.
Collapse
|
44
|
Gorle AK, Feterl M, Warner JM, Primrose S, Constantinoiu CC, Keene FR, Collins JG. Mononuclear Polypyridylruthenium(II) Complexes with High Membrane Permeability in Gram-Negative Bacteria-in particularPseudomonas aeruginosa. Chemistry 2015; 21:10472-81. [DOI: 10.1002/chem.201500385] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2015] [Indexed: 01/10/2023]
|
45
|
Momcilovic M, Eichhorn T, Blazevski J, Schmidt H, Kaluđerović GN, Stosic-Grujicic S. In vitro effects of binuclear (η (6)-p-cymene)ruthenium(II) complex containing bridging bis(nicotinate)-polyethylene glycol ester ligand on differentiation pathways of murine Th lymphocytes activated by T cell mitogen. J Biol Inorg Chem 2015; 20:575-83. [PMID: 25827592 DOI: 10.1007/s00775-015-1242-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2014] [Accepted: 01/19/2015] [Indexed: 12/24/2022]
Abstract
T cell differentiation into distinct T helper (Th) subpopulations is crucial in governing acquired immune responses as well as some inflammatory and autoimmune disorders. This study investigated potential of the novel neutral binuclear ruthenium(II) complexes 1-8 with general formula [{RuCl2(η(6)-p-cym)}2μ-(N(∩)N)] (N(∩)N = bis(nicotinate)- and bis(iso-nicotinate)-polyethylene glycol esters; (3-py)COO(CH2CH2O) n CO(3-py) and (4-py)COO(CH2CH2O) n CO(4-py); n = 1-4), as well as [RuCl2(η(6)-p-cym)(nic)] (R1, nic = nicotinate) and [RuCl2(η(6)-p-cym)(inic)] (R2, inic = isonicotinate) as an immunomodulatory agents capable to direct Th cell differentiation. From all investigated complexes, [{RuCl2(η(6)-p-cym)}2μ-{(3-py)COO(CH2CH2O)4CO(3-py)}] (4) was selected for further study because it did not affect splenocyte viability (in concentration up to 50 μM), but significantly reduced secretion of representative Th1 cytokine, IFN-γ induced by T cell mitogen. Besides IFN-γ, 4 inhibited dose dependently expression and production of representative Th17 cytokine, IL-17, in these cells. Otherwise, the production of anti-inflammatory cytokines IL-4 and IL-10 was upregulated. Also, 4 significantly increased CD4(+)CD25(+)FoxP3(+) Treg cell frequency in the activated splenocytes. Moreover, ConA-induced expression of Th1 transcription factors, T-bet and STAT1, as well as of Th17-related protein STAT3 was attenuated upon exposure to 4, while the expression of Th2-related transcription factor GATA3 remained stable. In conclusion, ruthenium(II) complex 4 modulates immune system cell functions in vitro by inhibiting T cell differentiation towards pathogenic Th1/Th17 phenotype and inducing a regulatory phenotype characterized by IL-10 and IL-4 production, which may provide novel therapeutic opportunities for immune-inflammatory and/or autoimmune disorders.
Collapse
Affiliation(s)
- Miljana Momcilovic
- Department of Immunology, Institute for Biological Research "Sinisa Stankovic", University of Belgrade, Bulevar Despota Stefana 142, 11060, Belgrade, Serbia,
| | | | | | | | | | | |
Collapse
|
46
|
Hassan EA, Hassan ML, Moorefield CN, Newkome GR. New supramolecular metallo-terpyridine carboxymethyl cellulose derivatives with antimicrobial properties. Carbohydr Polym 2015; 116:2-8. [DOI: 10.1016/j.carbpol.2014.06.056] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2013] [Revised: 06/17/2014] [Accepted: 06/18/2014] [Indexed: 12/25/2022]
|
47
|
Jain N, Alam P, Laskar IR, Panwar J. ‘Aggregation induced phosphorescence’ active iridium(iii) complexes for integrated sensing and inhibition of bacterial growth in aqueous solution. RSC Adv 2015. [DOI: 10.1039/c5ra10161a] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
The present study attempts to develop a sensitive method to utilize ‘aggregation induced emission (AIE)’ active iridium(iii) complexes as potential agents for “integrated” sensing and inhibition of bacterial growth in aqueous systems.
Collapse
Affiliation(s)
- Navin Jain
- Department of Biological Sciences
- Birla Institute of Technology and Science
- Pilani – 333031
- India
| | - Parvej Alam
- Department of Chemistry
- Birla Institute of Technology and Science
- Pilani – 333031
- India
| | - Inamur Rahaman Laskar
- Department of Chemistry
- Birla Institute of Technology and Science
- Pilani – 333031
- India
| | - Jitendra Panwar
- Department of Biological Sciences
- Birla Institute of Technology and Science
- Pilani – 333031
- India
| |
Collapse
|
48
|
Mononuclear ruthenium(II) and rhodium(III) complexes with S-[4-(2,2:6′,2″-terpyridin-4′-yl)phenoxy]butyl ethanethioate and 4′-[4-(1,2-dithiolane-3-yl)butylcarboxy)phenyl]-2,2′:6′,2″-terpyridine: Synthesis, electrochemistry, antibacterial activity and catalytical application. Polyhedron 2015. [DOI: 10.1016/j.poly.2014.09.037] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
49
|
Synthesis, structure, stability and antimicrobial activity of a ruthenium(II) helicate derived from a bis-bidentate “click” pyridyl-1,2,3-triazole ligand. Inorganica Chim Acta 2015. [DOI: 10.1016/j.ica.2014.10.011] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
50
|
Tripathy SK, Taviti AC, Dehury N, Sahoo A, Pal S, Beuria TK, Patra S. Synthesis, characterisation and antibacterial activity of [(p-cym)RuX(L)]+/2+ (X = Cl, H2O; L = bpmo, bpms) complexes. Dalton Trans 2015; 44:5114-24. [DOI: 10.1039/c4dt03647f] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Simple replacement of Cl− by H2O in {(p-cym)RuII(L)X]n+ (X = Cl or H2O) complexes enhances antibacterial activity significantly.
Collapse
Affiliation(s)
- Suman Kumar Tripathy
- School of Basic Sciences
- Indian Institute of Technology Bhubaneswar
- Bhubaneswar
- India
| | | | - Niranjan Dehury
- School of Basic Sciences
- Indian Institute of Technology Bhubaneswar
- Bhubaneswar
- India
| | - Anupam Sahoo
- School of Basic Sciences
- Indian Institute of Technology Bhubaneswar
- Bhubaneswar
- India
| | - Satyanaryan Pal
- Department of Chemistry
- Ravenshaw University
- Cuttack-753 003
- India
| | | | - Srikanta Patra
- School of Basic Sciences
- Indian Institute of Technology Bhubaneswar
- Bhubaneswar
- India
| |
Collapse
|